---
title: Reflecting on 2020
description: At FidoCure®, we were fortunate to make progress on our mission to advance canine cancer treatment, despite the challenges of 2020.
image: https://blog.fidocure.com/hubfs/Imported_Blog_Media/Reflecting2020-2071x1381--2-.png
---
[](https://www.fidocure.com/)
- [Veterinarians](https://fidocure.com/for-veterinarians/)
- [Portal Login](https://dvm.fidocure.com/)
- [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
- [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
- [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)
# Reflecting on 2020
[Christina K. Lopes](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes)
[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.fidocure.com/fidocure-blog/veterinary-oncology/blog/fidocure-reflecting-on-2020) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.fidocure.com/fidocure-blog/veterinary-oncology/blog/fidocure-reflecting-on-2020) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.fidocure.com/fidocure-blog/veterinary-oncology/blog/fidocure-reflecting-on-2020)
#### Thank you for being on the front lines and taking such good care of your patients.
We know it hasn't been easy and we appreciate you.
The pandemic upended our lives and how you practice veterinary medicine. Looking back, we’re extremely proud of our team, our community, and our industry for the way it has adjusted to incredible circumstances and still delivered medicine with care and compassion.
#### We are honored that you are all part of our FidoCure® community.
Thanks to the support of veterinary oncologists, nurses, technicians, administrative staff, and of course, devoted families, all of this was possible.
We’ve summarized the highlights of our year below.
#### The FidoCure® mission is to expand oncology toolbox and discover canine cancer breakthrough treatment options that:
- Provide **patients** a chance at a longer lifespan while maintaining quality of life
- Give **families** more time with their fur babies while leveraging cutting edge medicine already used to treat human cancers
- Increase the veterinary oncology toolbox for **veterinarians** who want to go above and beyond for their patients while staying at the forefront of their field
- Make our **team** proud of their contribution to animal and human well being
- Advance cancer care for the benefit of all **humans** and **dogs**
#### Together, we are closing the knowledge gap by learning with every patient.
Sending you and your loved ones a heartfelt thank you for everything we have accomplished together this year.
Happy Holidays and wishing you a wonderful New Year!
## Related Articles
[](https://blog.fidocure.com/fidocure-blog/fidocure-ceo-christina-lopes-to-showcase-worlds-only-portfolio-of-canine-cancer-drugs-at-2024-animal-health-summit)
### [FidoCure CEO Christina Lopes to Showcase World's First Portfolio of Canine Cancer Drugs at 2024 Animal Health Summit](https://blog.fidocure.com/fidocure-blog/fidocure-ceo-christina-lopes-to-showcase-worlds-only-portfolio-of-canine-cancer-drugs-at-2024-animal-health-summit)
FidoCure CEO Christina Lopes will present at the 2024 Animal Health Summit in Kansas City on August 26-27. The summit will showcase emerging companies and foster...
[Christina K. Lopes](https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes)
[Read More](https://blog.fidocure.com/fidocure-blog/fidocure-ceo-christina-lopes-to-showcase-worlds-only-portfolio-of-canine-cancer-drugs-at-2024-animal-health-summit)
[](https://blog.fidocure.com/fidocure-blog/hemangiosarcoma-advancing-canine-cancer-treatment-with-targeted-therapies)
### [Hemangiosarcoma: Advancing canine cancer treatment with targeted therapies](https://blog.fidocure.com/fidocure-blog/hemangiosarcoma-advancing-canine-cancer-treatment-with-targeted-therapies)
Canine cancer diagnoses can be devastating and demoralizing. While research and studies for human cancer have brought us a long way when it comes to treatment and...
[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure)
[Read More](https://blog.fidocure.com/fidocure-blog/hemangiosarcoma-advancing-canine-cancer-treatment-with-targeted-therapies)
- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)
-
-
-
-
**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.
© Copyright 2018-2026 One Health Company, All rights reserved
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "Christina K. Lopes",
"url" : "https://blog.fidocure.com/fidocure-blog/author/christina-k-lopes"
},
"dateModified" : "2023-04-05T18:55:27.791Z",
"datePublished" : "2020-12-23T05:00:00.000Z",
"headline" : "Reflecting on 2020",
"image" : [ "https://blog.fidocure.com/hubfs/Imported_Blog_Media/Reflecting2020-2071x1381--2-.png" ],
"mainEntityOfPage" : {
"@id" : "https://blog.fidocure.com/fidocure-blog/veterinary-oncology/blog/fidocure-reflecting-on-2020",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.fidocure.com/hubfs/fidocure_logo.png"
},
"name" : "FidoCure"
}
}
```